THC private equity fund has acquired a 75% stake in leading Polish gastroenterology facility Med-Gastr Medical Center, marking its first investment from the fourth fund in the healthcare sector.
Information on the Target
Private equity fund THC has acquired a 75% stake in Med-Gastr Medical Center, a leading gastroenterology facility located in central Poland. This transaction marks the first investment made by THC's fourth fund (THC IV), as well as being the third consolidation platform the fund has established in the healthcare sector. Founded in 2006 by Dr. Arkadiusz Mamos, Med-Gastr Medical Center has specialized for many years in providing comprehensive care for patients with gastrointestinal disorders.
The facility has gained a reputation for delivering high-quality medical services, blending advanced technology with expert care. Med-Gastr is dedicated to enhancing patient outcomes through innovative treatment approaches and an exceptional patient experience.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Poland
The healthcare industry in Poland has been experiencing significant transformation, driven by an ageing population and a growing demand for specialized medical services. With increased government investment in health infrastructure an
Similar Deals
Scanmed → Centrum Rehabilitacji Sp. z o.o.
2024
Skupina BHM → FAMED Żywiec
2023
Scanmed → Med-Lux Sp. z o.o.
2023
Labnet International, Inc. → PZ HTL S.A.
2023
THC
invested in
Centrum Medycznym Med-Gastr
in
in a Buy & Build / Roll-Up deal